Pradaxa is progress but conduct a search for Pradaxa on Google and right on top in the paid search are two ads for law firms recruiting patients to sue fBoehringer Ingelheim because of side effects. Considering that almost 90% of people looking for health information via a search engine you would think that BI would at least try and address the issue but like most pharma companies they are ignoring this damaging online advertising.
Read more »Pharmaceutical Marketing
How pharma ignores the news (an example) | World of DTC Marketing.com

Pfizer Gives Up Marketing Push for Lipitor - WSJ.com
Pfizer Inc. conducted an intriguing experiment in brand marketing this year, aggressively pushing the cholesterol-fighting drug Lipitor in the U.S. even after its patent expired on Nov. 30.
Read more »
Pharma's Use of Infographics
In the past year, the use of infographics has exploded. In fact, there are entire websites and search engines devoted to them. If you aren’t sure what I mean by the term “infographic,” I’m referring to graphically interesting representations of data. Ideally, infographics (short for information graphics) present complex information in an easy-to-understand visual format. If you’d like to learn more, here’s a post on the history of infographics.
Read more »
Will Emerging Markets Really Save Pharma? // Pharmalot
Some 40 years ago, Jim Morrison of The Doors sang that ‘the future’s uncertain and the end is always near.’ Such a bleak philosophy may not apply to the pharmaceutical industry, but global drugmakers do have their challenges, as a new report from KPMG, which makes clear that emerging markets will certainly be a growth driver, but the not the automatic salve that some suggest.
Read more »
2nd UPDATE: Abbott To Pay $1.6B To Settle Depakote Marketing Probes - WSJ.com
Abbott Laboratories (ABT) agreed to pay $1.6 billion and plead guilty to violating a federal drug law to resolve allegations that the company improperly promoted antiseizure drug Depakote for unauthorized uses.
Read more »
Study Shows Widespread Misuse of Prescription Drugs - Health Blog - WSJ
Nearly two out of three Americans don’t follow their doctor’s orders properly when taking prescription drugs, neglecting to take their medications or seeking out pills that weren’t intended for them, according to new research.
Read more »
Protect Your Clients: Social-Media Tips for the Heavily Regulated | Guest Columnists - Advertising Age
Companies in heavily regulated industries, such as financial services and pharmaceuticals, are looking for safer social-media options. While the promise of real-time engagement with customers is appealing, social presents regulatory challenges. Ad agencies must arm themselves with the proper information to help clients find the right balance between the creative use of social platforms and the security and controls required to meet complex compliance demands.
Read more »
4 ways pharma can interact with patient communities | Articles
As a patient advocate and the owner of an active social health community, cysticfibrosis.com, I liken patient health communities to islands of crystal gardens of holographic distortions. Members of these communities are trying to shed light on every imaginable topic in their treatment regimens. They are amazingly open, bright, curious, well versed and resourceful.
Read more »
Resource: Pharmaceutical Marketing Digital Handbook
Handbook developed by PM Live focusing on how pharmaceutical companies are utilizing digital technologies for a range of purposes.
Read more »
Facebook Timelines for Brands: The Implications for Pharma Companies
On February 29th Facebook announced sweeping changes to the way brands market on the platform, including coupon creation, premium ad products, real-time insights, and the introduction of Timeline for Brand Pages.
Read more »

